# A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

> **NCT04857307** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 14 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Alprazolam

## Key facts

- **NCT ID:** NCT04857307
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-28
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04857307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04857307, "A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04857307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*